Status:
COMPLETED
Saphenous Nerve Block Versus Platelet Rich Plasma for Chronic Knee Osteoarthritis
Lead Sponsor:
Mansoura University
Conditions:
Chronic Knee Joint Osteoarthritis
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
Knee osteoarthritis, as a progressive disease is one of the most common causes of pain, motor disorder and disability in the elderly. By increasing age, the cartilage is eroded and endures degenerativ...
Detailed Description
The aim of this study is to compare the efficacy of ultrasound guided saphenous nerve block versus platelet rich plasma injection in the management of chronic pain in patients with knee OA. This study...
Eligibility Criteria
Inclusion
- Patients who are not competent to understand the study protocol
- Radiographic evidence of OA of knee of 2nd degree.
- Chronic pain for at least 6 months prior to study entry (day 0).
- Pain relief not achieved with conservative therapies during the last 6 months
Exclusion
- Patient refusal.
- Bleeding disorders.
- Coagulation disorders.
- Local skin infection
- Current other problem in the affected extremity .
- Psychiatric disorders affecting co-operation of the patient .
- Previous chronic opioid use.
- Intra articular knee injection within previous three months.
- History of traumatic arthropathy.
- History of neuropathic arthropathy.
- Allergy or hypersensitivity to any of the study medication.
- Any condition that could interfere with the interpretation of the outcome assessments.
- Pregnancy
- Lactating women.
- low back pain due to central cause.
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2018
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03326544
Start Date
September 1 2017
End Date
September 30 2018
Last Update
September 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Hospitals
Al Mansurah, DK, Egypt, 050